De Caprio L, Acanfora D, Odierna L, Di Palma A, Romaniello C, Rengo C, Giordano A, Rengo F
Istituto di Medicina Interna, II Facoltá di Medicina e Chirurgia, Universitá degli Studi di Napoli, Italy.
Eur Heart J. 1993 Mar;14(3):416-20. doi: 10.1093/eurheartj/14.3.416.
We evaluated the acute therapeutic effects of the oral administration of nifedipine (10 mg) and diltiazem (120 mg) alone and in combination in 16 patients with effort angina. The 16 patients (13 men and three women; mean age 59 +/- 7 years) performed a symptom-limited bicycle exercise stress test 3 h after placebo or active substance administration. Maximal work load, exercise duration and time to 1 mm ST segment depression were significantly increased and ST depression at peak exercise was significantly decreased by the combination of drugs. Nifedipine and diltiazem alone similarly improved exercise duration as markedly as their combination. One patient stopped the test after all three treatments for angina associated with ST depression > 2 mm. The combination of drugs yielded the best symptomatic effect: only four patients complained of angina in comparison to eight and seven patients after diltiazem and nifedipine, respectively. Nifedipine and diltiazem are effective and safe antianginal drugs. Some patients respond better to one drug than to the other. Patients who remain symptomatic in spite of maximal doses of a single drug may derive some benefit from combination therapy.
我们评估了硝苯地平(10毫克)和地尔硫䓬(120毫克)单独及联合口服给药对16例劳力性心绞痛患者的急性治疗效果。这16例患者(13名男性和3名女性;平均年龄59±7岁)在服用安慰剂或活性物质3小时后进行了症状限制的自行车运动应激试验。联合用药使最大工作量、运动持续时间和出现1毫米ST段压低的时间显著增加,运动高峰时的ST段压低显著降低。硝苯地平和地尔硫䓬单独使用时对运动持续时间的改善程度与联合用药相似。有1例患者在接受所有三种治疗后因ST段压低>2毫米伴心绞痛而停止试验。联合用药产生了最佳的症状改善效果:与分别服用地尔硫䓬和硝苯地平后有8例和7例患者主诉心绞痛相比,联合用药后只有4例患者主诉心绞痛。硝苯地平和地尔硫䓬是有效且安全的抗心绞痛药物。一些患者对一种药物的反应比对另一种药物更好。尽管使用单一药物的最大剂量仍有症状的患者可能从联合治疗中获益。